Hidradenitis Suppurativa (HS) Active Not Recruiting Phase 4 Trials for Adalimumab (DB00051)

Also known as: Hidradenitis Suppurativa / Hidradenitis / Sweat gland inflammation / Acne inversa

IndicationStatusPhase
DBCOND0054533 (Hidradenitis Suppurativa (HS))Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02808975Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study)Treatment